Another ASX biotech in which Karst Peak Capital was invested was Viralytics, which was taken out by Merck in early 2018.
At the time of takeover, Karst Peak Capital was the No. 3 shareholder, holding 4.6% of the company.
Baker Bros. was also a Top 10 shareholder, with 3.9%.
Perhaps worth noting that neither was listed in Top 20 shareholder list in VLA's previous Annual Report. It seems likely an HSBC nominee account was used.
- Forums
- ASX - By Stock
- Ann: International institution acquires 14% of Neuren
Another ASX biotech in which Karst Peak Capital was invested was...
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$14.47 |
Change
-1.120(7.18%) |
Mkt cap ! $1.849B |
Open | High | Low | Value | Volume |
$15.38 | $15.40 | $14.40 | $9.160M | 624.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50 | $14.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.55 | 1764 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50 | 14.460 |
2 | 2041 | 14.450 |
3 | 8114 | 14.440 |
1 | 1732 | 14.430 |
1 | 400 | 14.420 |
Price($) | Vol. | No. |
---|---|---|
14.550 | 1764 | 2 |
14.610 | 2314 | 3 |
14.670 | 2041 | 1 |
14.690 | 1200 | 1 |
14.700 | 1983 | 1 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |